Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

common/albumin

Kiungo kimehifadhiwa kwenye clipboard
10 matokeo

Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
TECHNICAL FIELD This invention relates to generally to models for identifying and isolating pancreatic stem cells, and in one embodiment, to models for identifying and isolating a common stem/progenitor cell that gives rise to hepatic cells and pancreatic cells. BACKGROUND OF THE INVENTION A healthy

Afamin: a human serum albumin-like gene

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
FIELD OF THE INVENTION Generally, the invention relates to the field of human serum proteins that are functionally and structurally similar to the related proteins: human serum albumin (ALB), human a-fetoprotein (AFP), and vitamin D-binding protein (VDB). BACKGROUND OF THE INVENTION The human serum

Afamin: a human serum albumin-like protein

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
FIELD OF THE INVENTION Generally, the invention relates to the field of human serum proteins that are functionally and structurally similar to the related proteins: human serum albumin (ALB), human a-fetoprotein (AFP), and vitamin D-binding protein (VDB). BACKGROUND OF THE INVENTION The human serum

Methods of immunoregulation by albumin neo-structures

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
TECHNICAL FIELD The present invention relates to certain identified protein sequences having an immunoregulatory effect, as well as antibodies directed to such protein sequences and to methods for identifying such. BACKGROUND OF THE INVENTION Although data indicate that the immune system is of major

Methods, agents and kits for detection of organophosphorus compounds

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
The present invention relates to novel generic antibodies that are specific to groups of organophosphates, particularly to a class of organophosphate pesticides in common usage. Further provided are hapten compounds and methods for using them in raising these antibodies, test kits containing them

Hapten-protein conjugates for use in detection of organophosphorus compounds

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
The present invention relates to novel generic antibodies that are specific to groups of organophosphates, particularly to a class of organophosphate pesticides in common usage. Further provided are hapten compounds and methods for using them in raising these antibodies, test kits containing them

Targeting-enhanced anticancer nanoparticles and preparation methods of same

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
CROSS REFERENCE TO RELATED APPLICATIONS This application is a National Stage of International Application No. PCT/KR2013/004297 filed May 15, 2013, claiming priority based on Korean Patent Application No. 10-2013-0049297 filed on May 2, 2013, the contents of all of which are incorporated herein by

Targeting-enhanced anticancer nanoparticles and preparation methods of same

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
TECHNICAL FIELD This invention provides targeting-enhanced anticancer nanoparticles and preparation methods for the same. BACKGROUND ART Cancer is the most devastating disease to modern society because there are no effective treatments that do not incur side effects. Although many treatments are
This invention relates to a process of preparation of a physiological solution containing a mass of loaded cells in suspension, such cells having a concentration of material loaded therein designed for chemical or physical interaction with substances located outside of the cell membrane. In such a

Therapeutic nucleic acid-3' -conjugates

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
FIELD OF THE INVENTION The present invention relates to the field of nucleic acid-based therapeutics where nucleic acid stability and retention are improved by a 3' conjugation to a therapeutic protein. More specifically, the present invention relates to methods for production of aptamers, antisense
Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge